Shares of Zscaler, Inc. (NASDAQ:ZS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirty-four ratings firms that are currently covering the firm, Marketbeat Ratings reports. Nine research analysts have rated the stock with a hold recommendation, twenty-four have issued a buy recommendation and one has issued a strong […]

The Lovesac Company (NASDAQ:LOVE – Get Free Report) has received a consensus recommendation of “Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokers that have updated their coverage on […]

HCI Group, Inc. (NYSE:HCI – Get Free Report) has earned a consensus recommendation of “Buy” from the five ratings firms that are covering the stock, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the […]

Shares of West Fraser Timber Co. Ltd. (NYSE:WFG – Get Free Report) have been assigned a consensus rating of “Buy” from the five analysts that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. […]

Shares of Hancock Whitney Co. (NASDAQ:HWC – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average […]

Shares of Sony Group Co. (NYSE:SONY – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the four research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12 month […]

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average twelve-month price objective […]